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The most widely used techniques for graft preservation after localized graft infections are muscle flap closure or
antibacterial dressings and irrigations after débridement. Vacuum assisted closure (VAC) has been increasingly used for
complex wounds in vascular surgery, including groin infections, but not directly on exposed bypass grafts as a stand-alone
technique. We used the VAC system after wound débridement in four patients with fully exposed synthetic bypass grafts
who were too unstable or risky for further operative interventions. Mean duration of VAC use was 22.8 days (range, 6
to 53 days), with time to total wound closure of 30 to 63 days (mean, 41 days). There were no reinfections with 11 to 25
months’ follow-up (mean, 18.3 months). For high-risk surgical patients with a fully exposed infected prosthetic vascular
graft, VAC therapy along with aggressive débridement and antibiotic therapy may be an effective alternative to current
management strategies. ( J Vasc Surg 2005;42:989-92.)Groin infections involving vascular grafts are reported
to occur in 1% to 5% of bypasses and are associated with
10% to 70% amputation rates and 10% to 20% mortality
rates.1,2 Traditionally, graft excision and extra-anatomic or
in situ bypass have been the treatment of choice for the
treatment of infected bypass grafts. Because of the high
morbidity and mortality of these operations, various graft
preservation techniques have been increasingly utilized in
an attempt to improve outcomes.3-5
Graft preservation is feasible when the anastomosis is
intact, the whole graft is not involved with infection, the
patient has no systemic signs of sepsis, the graft is patent,
and the offending organism is not Pseudomonas aerginosa.6
Aggressive débridement, intravenous antibiotics, and vari-
ous muscle flaps have been the standard approach in these
patients, with a reported re-infection rate of 0% to 35%.7-11
Local wound care without muscle flap closure has been
reported in patients who are not candidates for a major
reoperation (high risk, extensive fibrosis, poor nutritional
status) with 75% initial success rate.10,12
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Kinetic Concepts, Inc, San Antonio, Tex) has been re-
ported extensively in a variety of wounds and as an adjunct
to débridement in exposed vascular graft infections before
muscle flap closure.9 The use of VAC systems without an
adjunctive muscle flap coverage has recently been reported
after repair of infected pseudoaneurysms13 as well as in post-
operative groin infections after patch angioplasties,14,15
bypass procedures using vein,16 and synthetic grafts with
minimal graft exposure.14 In this report, we share our
experience with the use of the VAC system in four patients
with fully exposed grafts as a less invasive means of graft
preservation and as an effective alternative to routine mus-
cle flap closure.
CASE REPORTS
A 69-year-old obese man with a history of stable angina and
tobacco abuse presented with disabling claudication at 20 yards
and an ankle-brachial index of 0.3 bilaterally. A transbrachial
angiogram showed juxtarenal aortic occlusion, and a right axillary-
bifemoral bypass was performed. He presented 12 days later with
left groin erythema and purulent drainage, fever (100.5°F), and
leukocytosis (white blood cell count of 20,000/mm3). Comput-
erized axial tomography (CT) scan showed a left groin fluid
collection extending to the anastomosis (Fig 1), and he was taken
to the operating room for débridement. This resulted in an 8- 
7-cm wound with exposed but intact anastomosis. The cultures
from the wound and blood grew methicillin-sensitive Staphylococ-
cus aureus (MSSA). The patient developed respiratory failure and
remained intubated for 12 days. A VAC system was placed because
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dramatically, and we transferred him to the rehabilitation floor on
postoperative day (POD) 29. The VAC was discontinued after
53 days and he was discharged home with a healed wound on
POD 67.
The patient received 3 months of culture-directed intravenous
antibiotics, and a repeat CT scan done 9 months postoperatively
showed no signs of infection (Fig 2). He remains free of infection
after 15 months.
Summary of all cases. All patients were men, with a mean
age of 58.8 (range, 44 to 68) (Table). The initial procedures were
performed for nonhealing wounds in two patients, rest pain in one,
and disabling claudication in one. All patients had polytetrafluoro-
ethylene (PTFE) grafts implanted. In addition, patient 2 had a
reversed greater saphenous vein-graft with inflow from an axillary-
femoral graft (PTFE) that had been performed for a failed aorto-
bifemoral graft.
The time to presentation with infection was 11 to 72 days. All
wounds were débrided in the operating room after local explora-
tion, a CT examination, or both, showed evidence of graft involve-
ment (Szilagy grade III). All except one patient had exposed
anastomoses after débridement, and the wounds measured be-
tween 2  3 cm and 7  8 cm. Cultures revealed methicillin-
resistant S. aureus (MRSA) (n 1), MSSA (n 1), Escherichia coli
Fig 1. The computed tomography scan at presentation shows left
groin fluid collection and inflammation around the graft.
Table. Patient characteristics
Patient Age
Initial
procedure
Time to
infection
(days) Organism
1 44 Fem-PT 11 Enterococci, S. epider
bacteroides
2 67 Fem-pop 14 E. coli
3 69 Ax-bifem 12 MSSA
4 55 Fem-PT 72 MRSA
LOS, Length of stay; Rehab, rehabilitation center; Fem-PT, femoral-poste
bypass; MSSA, methicillin susceptible S. aureus; VAC, vacuum assisted clos(n 1), and mixed infection (n 1). The albumin levels after thedébridement varied from 1.7 to 3.8 g/dL (mean SD, 2.5 0.91
g/dL).
Muscle flap closure was not attempted in these patients be-
cause of poor medical condition or because they had multiply
operated groins with severe fibrosis. Instead, the VAC system was
applied beginning 1 to 3 days after the initial débridement. Con-
stant suction (125 mm Hg) was used. Nonadhering dressing
(Kendall, Curity, Tyco Healthcare, Mansfield, Mass) or Silvasorb
silver antimicrobial perforated sheet (Medline, Mundelein, Ill)
were used to keep the sponge from coming in direct contact with
the anastomoses. Repeat minor débridements were performed at
bedside when needed (2 to 3 times per patient), with no repeat
major débridements needed in the operating room. All patients
were kept on culture-directed intravenous antibiotics for 6 to 24
weeks, depending on the exposure of the anastomoses and the
virulence of the cultured bacteria.
Mean duration of VAC use was 22.8 days (range, 6 to 53
days). The time to total wound closure was 30 to 63 days (mean,
41 days). The hospital stay was 11 to 31 days (mean, 21 days). The
length of rehabilitation center stay was 0 to 57 days (mean, 34
days). After the development of granulation tissue around the
exposed anastomoses, two patients were sent to a rehabilitation
center with VAC systems for 13 and 28 days.
There were no re-infections with 11 to 25 months’ follow-up
Fig 2. The computed tomography (CT) scan 9 months after the
previous CT scan shows no signs of infection.
Duration VAC use/
hospital LOS/
rehab LOS (days)
Wound
closure (days)
Follow up (months)/
reinfection/graft
, 11/13/42 33 25/no/intact,
occluded
6/31/0 30 22/no/intact
53/29/38 63 15/no/intact
21/11/57 38 11/no/intact
bial bypass; Fem-pop, femoropopliteal bypass; Ax-bifem, axillary bifemoralmidis(mean, 18.3 months). One patient who had femoral endarterec-
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at 14 months. This patient has a healed wound, with nondisabling
claudication and an intact uninfected graft.
DISCUSSION
Groin infections after bypass procedures remain a ma-
jor source of morbidity and mortality.1,2 Graft removal
with either in situ or extra-anatomic bypass remains the
standard treatment for patients with a disrupted anastomo-
sis, total graft infection, uncontrolled sepsis, an occluded
infected graft, or Pseudomonas infection.6 However, graft
preservation techniques have been developed in lieu of
graft removal because of the high morbidity and mortality
associated with this approach. Graft preservation ap-
proaches include radical débridement followed by muscle
flap closure simultaneously or later in good-risk patients
when feasible. Local wound care without muscle flap clo-
sure has been reported with varying degrees of success, and
up to 75% of patients may completely heal with this ap-
proach alone.10
The role of muscle flap closure of exposed grafts is well
documented and is associated with a 90% initial success
rate. However, re-infection may occur in as many as 35% of
patients,7 and a significant number of patients are not good
candidates for muscle flap closure secondary to poor med-
ical condition or inadequate nutritional status.
VAC therapy has been increasingly used in wounds
with exposed bone, tendons, and hardware and recently has
been reported as an adjunctive measure after groin infec-
tions involving exposed bypass grafts as a means of decreas-
ing the time to granulation tissue formation before muscle
flap closure.9 These investigators used the VAC system in
four of nine patients, after initial débridement, for 3 to 14
days before a muscle flap was used to cover the graft. The
time to flap closure was 5 days shorter in the patients with
VAC use, although the difference was not significant be-
cause of the small sample size.
VAC therapy has been used after infected pseudoaneu-
rysm débridement with primary or vein patch closure of the
femoral artery,13 after groin infections following endarter-
ectomy and synthetic patch closure,14,15 and after an in-
fected groin wound with an exposed vein graft.16 Pinocy
et al14 reported on the use of VAC without any muscle
coverage in 24 patients with groin infections. The series
included 18 patients with synthetic patches after endarter-
ectomy and six patients with aortobifemoral bypass grafts,
with 100% healing without re-infection in 12 months. The
authors used the VAC as a modified closed-suction drain
system, suturing the skin closed over the sponge in most of
the patients. Three patients with large wounds required an
adhesive system rather than temporary skin closure, as was
the case with all of the patients in our series. The wounds
were re-explored at 7 days with a new sponge placed, and all
wounds were primarily closed after 14 days. In their report,
graft exposure was defined as visualization of suture or graft
material in the wound. At the time of débridement, the
authors avoided contact with the vessel and prosthesis “to
avoid spreading the infection.”14 Compared with thosedescribed in our report, the wounds treated in their series
seem less extensive, with minimal graft exposure. All pa-
tients in our series had necrotic infected tissue in contact
with the prosthetic grafts, with associated large skin defects
that precluded primary skin closure.
The effect of VAC on the reduction of bacterial content
in wounds has been reported.17 Removing excess fluid
from the wound may cause increased lymphatic and blood
flow, with greater amounts of oxygen available for oxidative
burst causing bacterial killing. One concern with the VAC
use on exposed grafts is the closeness of the sponge to the
anastomosis, artery, or the vein-graft itself, and a nonadher-
ent dressing use between the graft and the VAC sponge has
proven to be effective in our and others’ experiences.9
The impact of VAC closure on the length of hospital
stay is difficult to evaluate from this limited experience.
However, two of the four patients in our small series were
discharged from the hospital (to home or rehabilitation
center) with an additional 13 and 28 days of VAC use.
Further evaluation is needed to understand if use of the
VAC system results in shortened hospital stays for patients
with graft infections.
After initial débridement, use of VAC system on ex-
posed grafts appears to be safe. The VAC may be used as a
bridge to muscle flap closure while providing time to
resuscitate the critically ill and unstable patient, improve
nutritional status, and control infection with repeat
débridements and intravenous antibiotics. Our experience
supports the notion that in those who continue to be poor
candidates for muscle flap closure, or if the graft is totally
covered with granulation tissue before a muscle flap is
attempted, the VAC system may end up being the only
modality utilized for wound closure, with complete wound
healing expected in most patients. We share the impression
of Colwell et al9 that the VAC system may speed the process
of granulation tissue formation. However, more data are
needed to compare VAC closure with other local wound
treatments.
CONCLUSION
The VAC system appears to be safe and effective for
patients with prosthetic graft infections in a selected group
of patients. To our knowledge, this is the first report of the
stand-alone use of VAC system in the treatment of wound
infections with fully exposed vascular bypass grafts, and
anastomoses.
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